Pléiade Investissement SAS SCR, Jean-Charles Deconninck, Aïda Collette-Sène, Ludovic Luzza and Philippe Seguin made an offer to acquire 32.8% of stake in Generix SA (ENXTPA:GENX) for €70.5 million on April 22, 2022. The buyer is paying €9.50 per share plus an additional price of €0.50 per share in the event that the threshold of 90% for the implementation of the squeeze-out is reached at the end of the offer. The closing of the Tender Offer could occur by the end of July 2022.

Laurent Bensaid of King and Spalding LLP (Paris) acted as legal advisor to Montefiore Investment.